Palisade Bio, Inc.
DE ˙ DB
SecurityDE:7NS0 / Palisade Bio, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership280,650 shares
Latest Disclosed Value $ 491,138
Northern Trust Corp reports 0.88% decrease in ownership of 7NS0 / Palisade Bio, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 280,650 shares of Palisade Bio, Inc. (DE:7NS0) valued at $491,138 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 283,147 shares of Palisade Bio, Inc.. This represents a change in shares of -0.88% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F PALISADE BIO COM 696389402 280,650 -2,497 -0.88 491 -26.17 0.0000
2026-02-17 2025-12-31 13F PALISADE BIO COM 696389402 283,147 283,147 665 0.0000
2023-02-13 2022-12-31 13F PALISADE BIO COM 696389105 0 -23,186 -100.00 0 -100.00
2022-11-14 2022-09-30 13F PALISADE BIO COM 696389105 23,186 0 0.00 2 -77.78 0.0000
2022-08-12 2022-06-30 13F PALISADE BIO COM 696389105 23,186 0 0.00 9 -64.00 0.0000
2022-05-13 2022-03-31 13F PALISADE BIO COM 696389105 23,186 0 0.00 25 -16.67 0.0000
2022-02-08 2021-12-31 13F PALISADE BIO COM 696389105 23,186 23,186 30 0.0000
2021-08-13 2021-06-30 13F SENECA BIOPHARMA COM 81689B103 0 -18,426 -100.00 0 -100.00
2021-05-12 2021-03-31 13F SENECA BIOPHARMA COM 81689B103 18,426 0 0.00 31 93.75 0.0000
2021-02-11 2020-12-31 13F SENECA BIOPHARMA COM 81689B103 18,426 18,426 16 0.0000
2020-11-16 2020-09-30 13F SENECA BIOPHARMA COM 81689B103 0 -11,961 -100.00 0 -100.00
2020-08-14 2020-06-30 13F SENECA BIOPHARMA COM 81689B103 11,961 -129,502 -91.54 9 -76.92 0.0000
2017-02-13 2016-12-31 13F NEURALSTEM COM 64127R302 141,463 5,271 3.87 39 -11.36 0.0000
2016-11-09 2016-09-30 13F NEURALSTEM COM 64127R302 136,192 0 0.00 44 12.82 0.0000
2016-08-12 2016-06-30 13F NEURALSTEM COM 64127R302 136,192 0 0.00 39 -61.76
2016-08-19 2016-03-31 13F/A-1 NEURALSTEM COM 64127R302 136,192 0 0.00 102 -27.14 0.0000
2016-05-13 2016-03-31 13F NEURALSTEM COM 64127R302 136,192 102
2016-02-12 2015-12-31 13F NEURALSTEM COM 64127R302 136,192 0 0.00 140 -15.66 0.0000
2015-11-12 2015-09-30 13F NEURALSTEM COM 64127R302 136,192 136,192 0.00 166
2015-08-13 2015-06-30 13F NEURALSTEM COM 64127R302 0 -789,159 -100.00 0 -100.00
2015-05-14 2015-03-31 13F NEURALSTEM COM 64127R302 789,159 20,602 2.68 1,500 -28.26 0.0005
2015-02-12 2014-12-31 13F NEURALSTEM COM 64127R302 768,557 -25,691 -3.23 2,091 -19.76 0.0006
2014-11-13 2014-09-30 13F NEURALSTEM COM 64127R302 794,248 561,907 241.85 2,606 165.65 0.0008
2014-08-14 2014-06-30 13F NEURALSTEM COM 64127R302 232,341 94,429 68.47 981 69.72 0.0003
2014-05-14 2014-03-31 13F NEURALSTEM COM 64127R302 137,912 20,164 17.12 578 68.51 0.0002
2014-02-21 2013-12-31 13F/A-1 NEURALSTEM COM 64127R302 117,748 23,028 24.31 343 33.46 0.0001
2014-02-12 2013-12-31 13F NEURALSTEM COM 64127R302 117,748 343
2013-11-13 2013-09-30 13F NEURALSTEM COM 64127R302 94,720 -1,866 -1.93 257 78.47 0.0001
2013-08-09 2013-06-30 13F NEURALSTEM COM 64127R302 96,586 96,586 144 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.